| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,110 |
8,774 |
$728K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,334 |
8,674 |
$634K |
| 36415 |
Collection of venous blood by venipuncture |
10,198 |
7,030 |
$334K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,173 |
4,826 |
$329K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,124 |
959 |
$235K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,467 |
2,708 |
$145K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,431 |
1,128 |
$145K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
493 |
409 |
$105K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,793 |
413 |
$88K |
| 80053 |
Comprehensive metabolic panel |
8,674 |
6,613 |
$69K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
487 |
212 |
$58K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
464 |
401 |
$34K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,203 |
965 |
$33K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
431 |
363 |
$30K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,751 |
1,383 |
$26K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
299 |
271 |
$26K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,862 |
2,389 |
$24K |
| 87081 |
|
1,286 |
1,159 |
$22K |
| 71045 |
Radiologic examination, chest; single view |
4,910 |
3,932 |
$21K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
214 |
175 |
$19K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,945 |
1,534 |
$17K |
| 81025 |
|
1,838 |
1,625 |
$15K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,378 |
1,161 |
$14K |
| 82947 |
|
1,079 |
491 |
$14K |
| 71046 |
Radiologic examination, chest; 2 views |
439 |
377 |
$13K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
511 |
401 |
$12K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
75 |
65 |
$12K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,237 |
1,070 |
$10K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,975 |
3,892 |
$9K |
| 81001 |
|
3,229 |
2,708 |
$9K |
| 73630 |
|
367 |
324 |
$9K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
731 |
611 |
$8K |
| 81003 |
|
2,061 |
1,730 |
$8K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
32 |
25 |
$8K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,210 |
4,087 |
$6K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
408 |
345 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,313 |
7,778 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
531 |
458 |
$5K |
| 84484 |
|
3,458 |
1,999 |
$5K |
| 82962 |
|
915 |
496 |
$5K |
| 00811 |
|
85 |
71 |
$4K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
134 |
63 |
$4K |
| 00731 |
|
140 |
117 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,333 |
2,392 |
$3K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
90 |
72 |
$3K |
| J2704 |
Injection, propofol, 10 mg |
3,215 |
2,204 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
56 |
51 |
$2K |
| 73562 |
|
111 |
96 |
$2K |
| 73130 |
|
72 |
69 |
$2K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
15 |
12 |
$2K |
| 73110 |
|
47 |
42 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,401 |
1,269 |
$2K |
| 71250 |
|
36 |
30 |
$2K |
| 85610 |
|
1,645 |
1,266 |
$2K |
| G0378 |
Hospital observation service, per hour |
358 |
177 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
19 |
14 |
$1K |
| 97161 |
|
91 |
68 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,332 |
1,780 |
$1K |
| 86900 |
|
128 |
96 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,997 |
2,767 |
$1K |
| 76830 |
Ultrasound, transvaginal |
14 |
13 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,772 |
1,468 |
$970.70 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,658 |
989 |
$950.14 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
32 |
31 |
$876.68 |
| 83690 |
|
2,493 |
2,045 |
$838.78 |
| 85379 |
|
425 |
357 |
$807.14 |
| 86901 |
|
127 |
95 |
$794.10 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
285 |
243 |
$745.37 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,660 |
2,785 |
$731.78 |
| 73610 |
|
89 |
76 |
$708.64 |
| 83605 |
|
543 |
419 |
$673.35 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
43 |
37 |
$652.72 |
| 84600 |
|
75 |
55 |
$467.77 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
668 |
540 |
$453.55 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
12 |
12 |
$429.64 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
737 |
556 |
$402.20 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,478 |
2,813 |
$354.33 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
17 |
14 |
$300.61 |
| 84703 |
|
1,053 |
918 |
$289.47 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,441 |
857 |
$276.36 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
570 |
430 |
$255.17 |
| 83880 |
|
863 |
703 |
$246.34 |
| 85730 |
|
506 |
376 |
$238.43 |
| 80050 |
General health panel |
27 |
25 |
$236.01 |
| 88342 |
|
412 |
332 |
$212.97 |
| 87040 |
|
536 |
237 |
$122.90 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
914 |
353 |
$119.49 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
353 |
303 |
$85.65 |
| J2060 |
Injection, lorazepam, 2 mg |
316 |
231 |
$77.92 |
| 85027 |
|
62 |
41 |
$60.79 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
286 |
184 |
$60.60 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
625 |
577 |
$42.03 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
308 |
181 |
$40.00 |
| 87428 |
|
48 |
45 |
$23.30 |
| 87186 |
|
108 |
93 |
$20.98 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
106 |
91 |
$19.73 |
| 84702 |
|
154 |
121 |
$13.92 |
| 84443 |
Thyroid stimulating hormone (TSH) |
39 |
33 |
$11.52 |
| 86850 |
|
35 |
26 |
$8.22 |
| 83735 |
|
337 |
252 |
$6.10 |
| 82150 |
|
184 |
149 |
$5.94 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
66 |
56 |
$1.56 |
| 94760 |
|
134 |
70 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
271 |
250 |
$0.00 |
| 87807 |
|
111 |
102 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
73 |
51 |
$0.00 |
| 82550 |
|
17 |
13 |
$0.00 |
| 96376 |
|
34 |
26 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
59 |
54 |
$0.00 |
| 87088 |
|
60 |
54 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
29 |
26 |
$0.00 |
| 85651 |
|
18 |
13 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
28 |
13 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
361 |
183 |
$0.00 |
| 80061 |
Lipid panel |
89 |
79 |
$0.00 |
| 90715 |
|
13 |
12 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
25 |
24 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
13 |
12 |
$0.00 |
| 88313 |
|
14 |
12 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
16 |
12 |
$0.00 |